Skip to main content

Advertisement

Log in

The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The paucity of information on the effect of long-term high-dose salmon calcitonin administration on normal bone mineral metabolism and histology prompted an investigation of the influence of high-dose synthetic calcitonin in the rat. Serum ionized calcium, osteocalcin or BGP (bone gla protein), and immunoreactive PTH were measured serially during calcitonin administration and bone histomorphometry analyzed at 6 weeks (after sacrifice). Daily injections of salmon calcitonin, 0.4 IU/100 g (group B) and 2 IU/100 g (group C), resulted in significant hypocalcemia at 4 hours for both experimental groups (P<0.004). Serium iPTH was significantly higher over the study period for both groups administered calcitonin. Serum BGP levels were significantly lower than controls during the study in group C (P<0.002) and to a lesser extent in group B (P<0.05). In group C, bone histomorphometry revealed increased resorption (onteoclast count), decreased trabecular bone volume, and decreased double-labeled tetracycline surface (bone formation). In group B an increase in osteoclast count but no alteration in bone formation was observed. To assess the role of PTH in the above findings, high-dose calcitonin was administered to parathyroidectomized rats. All of the above changes in bone histomorphometry were not observed in this group of animals. In conclusion, high doses of calcitonin promote hypocalcemia, secondary hyperparathyroidism, and osteoclastosis in the normal rat in a dose-dependent manner with very high-dose calcitonin impairing bone formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget's disease: quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthr Rheum 23:1095

    CAS  Google Scholar 

  2. Greenberg PB, Doyle FH, Fisher MT, Hillyard CJ, Joplin GF, Pennock J, MacIntyre I (1974) Treatment of Paget's disease of bone with synthetic human calcitonin biochemical and roentgenologic changes. Am J Med 56:867

    Article  PubMed  CAS  Google Scholar 

  3. Galante L, Joplin GF, MacIntyre I, Woodhouse NJY (1973) The calcium-lowering effect of synthetic human, porcine and salmon calcitonin in patients with Paget's disease. Clin Science 44:605

    CAS  Google Scholar 

  4. Ziegler R, Holz G, Rave F, Minne H, Delling G (1977) Therapeutic studies with human calcitonin. In: MacIntyre I (ed) Human calcitonin and Paget's disease, 167 H Huber, Bern, Switzerland

    Google Scholar 

  5. Friedman J, Raisz LG (1965) Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science 150:1465

    Article  PubMed  CAS  Google Scholar 

  6. Ziegler R, Deutschle U, Raue F (1984) Calcitonin in human pathophysiology. Hormone Res 20:65

    Article  PubMed  CAS  Google Scholar 

  7. Delling GR, Schulz A, Ziegler R (1977) Changes of bone remodeling surfaces as bone structure in Paget's disease following long-term treatment with calcitonin. Calcif Tissue Res 22 (suppl):359

    PubMed  Google Scholar 

  8. Hurley DL, Tiegs DR, Wahner HW, Heath H (1987) Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 317:537

    Article  PubMed  CAS  Google Scholar 

  9. Chambers TJ, Magnus CJ (1982) Calcitonin alters behavior of isolated osteoclasts. J Pathol 136:27

    Article  PubMed  CAS  Google Scholar 

  10. Holtrop ME, Raisz LG, Simmons HA (1974) The effects of parathyroid hormone, colchicine and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 60:346

    Article  PubMed  CAS  Google Scholar 

  11. Baron R, Vignery A (1981) Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats. Metab Bone Dis Rel Res 2:339–346

    Article  CAS  Google Scholar 

  12. Ekeland A, Underdal T (1983) Effects of salmon calcitonin on systhesis and mineralization of collagen in rats. Acta Orthop Scand 54:470–478

    PubMed  CAS  Google Scholar 

  13. Price PA, Lothringer JW, Nishimoto SK (1980) Absence of the vitamin K-dependent bone protein in fetal rat mineral. Evidence for another gamma-carboxyglutamic acidcontaining component in bone. J Biol Chem 255:2938

    PubMed  CAS  Google Scholar 

  14. Jowell P, Epstein S, Fallon MD, Ismail F (1987) 1,25 Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum BGP and bone histomorphometry. Endocrinology 120:531

    PubMed  CAS  Google Scholar 

  15. Toverud SU, Boass A, Gardner SC, Endres DB (1986) Circulating parathyroid hormone concentrations in normal and vitamin D-deprived rap pups determined with an N-terminal specific radioimmunoassay. Bone and Mineral 1:145–155

    PubMed  CAS  Google Scholar 

  16. Deftos LJ, First BP (1981) Calcitonin as a drug. Ann Int Med 95:192

    PubMed  CAS  Google Scholar 

  17. Hedlund T, Hulth A, Johnell O (1983) Early effects of parathormone and calcitonin on the number of osteoclasts and on serum calcium in rats. Acta Orthop Scand 54:802

    Article  PubMed  CAS  Google Scholar 

  18. Gennari C, Chierichetti SM, Bigazzi S, Fusi S (1985) Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 38:455–464

    Google Scholar 

  19. Freed WJ, Perlow MJ, Wyatt RJ (1979) Calcitonin: inhibitory effect on eating in rats. Science 206:850

    Article  PubMed  CAS  Google Scholar 

  20. Shires R, Avioli LV, Bergfeld MA, Fallon MD, Slotopolsky E, Teitelbaum SL (1980) Effects of semi-starvation on skeletal homeostasis. Endocrinology 107:1530

    PubMed  CAS  Google Scholar 

  21. Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism: measurement by radioimmunoassay of BGP in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:818

    Google Scholar 

  22. Slovitz DM, Gundberg CM, Neer RM, Lian JB (1984) Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 59:228

    Google Scholar 

  23. Ismail F, Epstein S, Fallon MD, Thomas SB, Reinhardt TA (1988) Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat. Endocrinology 122:624–630

    Article  PubMed  CAS  Google Scholar 

  24. Gundberg CM, Cole DEC (1985) Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphosphatemic rickets. Clin Chem Acta 151:1

    Article  Google Scholar 

  25. Calvo SM, Fryer MJ, Laakso JK, Nissenson RA, Price PA, Murray TM, Heath H (1985) Structural requirements for parathyroid hormone action in mature bone. J Clin Invest 76:2348

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glajchen, N., Thomas, S., Jowell, P. et al. The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat. Calcif Tissue Int 46, 28–32 (1990). https://doi.org/10.1007/BF02555821

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02555821

Key words

Navigation